Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-22-000091
Filing Date
2022-01-25
Accepted
2022-01-25 15:14:33
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q amgreat20210930_10q.htm   iXBRL 10-Q 560979
2 EXHIBIT 31.1 ex_327490.htm EX-31.1 8842
3 EXHIBIT 32.1 ex_327491.htm EX-32.1 4336
  Complete submission text file 0001185185-22-000091.txt   3588235

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aagh-20210930.xsd EX-101.SCH 31368
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aagh-20210930_cal.xml EX-101.CAL 29380
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aagh-20210930_def.xml EX-101.DEF 185876
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aagh-20210930_lab.xml EX-101.LAB 291883
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aagh-20210930_pre.xml EX-101.PRE 192779
49 EXTRACTED XBRL INSTANCE DOCUMENT amgreat20210930_10q_htm.xml XML 354988
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 22553622
SIC: 2834 Pharmaceutical Preparations